New 2020 National and State Healthcare-Associated Infections Progress Report
2020 National and State Healthcare-Associated Infections (HAI) Progress Report Shows Increases in Some HAIs |
|---|
CDC has released the 2020 National and State Healthcare-Associated Infections (HAI) Progress Report showing significant increases between 2019 and 2020 in some HAIs for some facility types, including: a 35% increase in the standardized infection ratio (SIR) for ventilator-associated events (VAEs), 24% increase in central line-associated bloodstream infections (CLABSI), and a 15% increase in hospital-onset methicillin-resistant Staphylococcus aureus (MRSA) for acute care hospitals. While some infections increased between 2019 and 2020, all 2020 national SIRs except VAEs remain below the 2015 baseline SIR of 1, or a “reference point” for measuring progress, in acute care hospitals. Other HAIs were unchanged between 2019 and 2020 or showed a significant decrease. This progress in infection prevention is a testament to the dedication of healthcare providers across the country to protect patients from harm despite unprecedented challenges in 2020.
The report includes data reported to the National Healthcare Safety Network (NHSN) across four healthcare settings: acute care hospitals, critical access hospitals, inpatient rehabilitation facilities (IRFs), and long-term acute care hospitals (LTACHs).
|
|---|
2020 National Data by HAI Type for General Acute Care Hospitals |
|---|
 |
|---|
CAUTI: catheter-associated urinary tract infections CDI: C. difficile infections COLON: surgical site infection from colon surgery HYST: surgical site infection from abdominal hysterectomy |
|---|
In 2020, many hospitals faced extraordinary circumstances that may have reduced the implementation of standard infection prevention and control (IPC) practices. In acute care hospitals, the increases seen in some HAIs in 2020 contrast with the success in reducing these infections prior to the pandemic. Despite the challenges of the COVID-19 pandemic, acute care hospitals in more than half of states are performing better than the 2015 national baseline in preventing CLABSI, CAUTI, SSIs following surgeries, MRSA bacteremia and C. difficile infections. These findings are consistent with increases of some HAIs in hospitals reported in the one-time study by Weiner-Lastinger, L et al, Impact of COVID-19 on HAIs in 2020: A summary of data reported to NHSN published in September 2021. The 2020 HAI Progress Report also shows progress in reducing some HAIs in other healthcare settings. In LTACHs, significant reductions were seen in CLABSI, CAUTI, and LTACH-onset CDI, while no significant changes were observed in VAE. In IRFs, significant reductions were seen in hospital-onset CDI, CLABSI, and CAUTI, while no significant changes were observed in IRF-onset MRSA bacteremia. The 2020 HAI Progress Report highlights the need for healthcare to continue to reinforce IPC practices in their facilities and regularly review HAI surveillance data to identify areas that need to be improved, plus address any gaps in prevention practices. CDC remains committed to protecting patients and promoting safety, quality, and value in healthcare delivery. Read the full 2020 HAI Progress Report, including the executive summary, data tables, and technical appendix and frequently asked questions. Data for the HAI Progress Report are also available in CDC’s Antibiotic Resistance & Patient Safety Portal (AR&PSP), an interactive web-based application that shows data collected through CDC’s NHSN and other sources.
|
|---|
New 2020 National and State HAI Progress Report shows increases in some healthcare-associated infections between 2019 and 2020. Explore current data in @CDCgov’s Antibiotic Resistance & Patient Safety Portal: https://arpsp.cdc.gov/profile/national-progress/united-states  |
|---|
|
|---|
